Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
150 |
|
| Actual shortage: | 5 (3%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 4 (3%) | |
| Resolved: | 139 (93%) | |
Discontinuation Reports |
51 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 51 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (17%) |
|
Overdue reports |
1 (14%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MAXITROL | 6000UNIT 3.5MG 0.1% | SUSPENSION | Resolved | 2022-04-11 | 2022-06-17 | 158484 |
| MAXITROL | 6000UNIT 3.5MG 0.1% | SUSPENSION | Resolved | 2022-10-25 | 2023-01-25 | 172560 |
| MAXIDEX | 0.1% | SUSPENSION | Resolved | 2019-10-25 | 2020-02-27 | 97281 |
| MAXIDEX | 0.1% | SUSPENSION | Resolved | 2020-05-05 | 2020-06-17 | 114093 |
| MAXIDEX | 0.1% | SUSPENSION | Resolved | 2022-09-29 | 2024-01-30 | 170485 |
| LOPRESOR 100MG | 100MG | TABLET | Resolved | 2017-05-29 | 2018-01-09 | 11438 |
| CILOXAN | 0.3% | OINTMENT | Resolved | 2019-02-11 | 2019-04-29 | 75343 |
| CILOXAN | 0.3% | OINTMENT | Resolved | 2019-06-05 | 2019-08-02 | 85629 |
| ZOFRAN | 2MG | SOLUTION | Resolved | 2018-02-22 | 2018-04-09 | 40627 |
| TOBREX | .3% | SOLUTION | Resolved | 2017-09-05 | 2017-09-14 | 20963 |
| TOBREX | .3% | SOLUTION | Resolved | 2018-12-11 | 2019-02-05 | 69257 |
| MAXIDEX | 0.1% | OINTMENT | Resolved | 2017-07-27 | 2017-09-08 | 17417 |
| MAXIDEX | 0.1% | OINTMENT | Resolved | 2018-01-09 | 2018-01-19 | 35401 |
| MAXIDEX | 0.1% | OINTMENT | Resolved | 2018-08-28 | 2019-02-05 | 59391 |
| ZOFRAN | 4MG | SOLUTION | Resolved | 2019-02-15 | 2019-04-09 | 75937 |
| ZOFRAN | 4MG | SOLUTION | Resolved | 2019-12-16 | 2020-01-30 | 101443 |
| FORADIL DRY POWDER CAPSULES FOR INHALATION | 12MCG | CAPSULE | Resolved | 2020-07-16 | 2020-09-09 | 120516 |
| FORADIL DRY POWDER CAPSULES FOR INHALATION | 12MCG | CAPSULE | Resolved | 2021-08-23 | 2021-09-28 | 144463 |
| LOPRESOR SR 200 MG | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-03-21 | 2019-08-12 | 79076 |
| LOPRESOR SR 200 MG | 200MG | TABLET (EXTENDED-RELEASE) | Resolved | 2019-03-21 | 2019-08-12 | 79079 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ONBREZ BREEZHALER | 75MCG | CAPSULE | Discontinued | 2022-06-29 | 2022-07-14 | 163682 |
| ZOFRAN | 4MG | SOLUTION | Discontinued | 2022-06-29 | 2022-10-18 | 163685 |
| BETOPTIC S | 0.25% | SUSPENSION | Discontinued | 2022-09-28 | 2023-01-19 | 170389 |
| FORADIL DRY POWDER CAPSULES FOR INHALATION | 12MCG | CAPSULE | Discontinued | 2022-10-18 | 2023-01-25 | 172087 |
| ZOFRAN | 4MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189513 |
| ZOFRAN | 8MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189538 |
| LIORESAL INTRATHECAL 2MG/ML | 2MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201573 |
| LIORESAL INTRATHECAL 0.05MG/ML | 0.05MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201576 |
| LIORESAL INTRATHECAL 0.5MG/ML | 0.5MG | SOLUTION | Discontinued | 2023-08-17 | 2023-09-19 | 202298 |
| TASIGNA | 50MG | CAPSULE | Discontinued | 2023-10-19 | 2023-11-06 | 207564 |
| SANDOSTATIN | 100MCG | SOLUTION | Discontinued | 2024-03-22 | 2024-03-22 | 223070 |